These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30690693)

  • 1. Exenatide Delays Gastric Emptying in Patients with Type 2 Diabetes Mellitus but not in Those with Gastroparetic Conditions.
    Beti C; Stratmann B; Bokman G; Dreier J; Hauber M; Lee-Barkey YH; Fischer M; Knabbe C; Tschoepe D
    Horm Metab Res; 2019 Apr; 51(4):267-273. PubMed ID: 30690693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus.
    Schirra J; Leicht P; Hildebrand P; Beglinger C; Arnold R; Göke B; Katschinski M
    J Endocrinol; 1998 Jan; 156(1):177-86. PubMed ID: 9496247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of gastric emptying in diabetes.
    Phillips LK; Rayner CK; Jones KL; Horowitz M
    J Diabetes Complications; 2014; 28(6):894-903. PubMed ID: 25047170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of gastric emptying by 13C-octanoic acid breath test versus scintigraphy in diabetics.
    Zahn A; Langhans CD; Hoffner S; Haberkorn U; Rating D; Haass M; Enck P; Stremmel W; Rühl A
    Z Gastroenterol; 2003 May; 41(5):383-90. PubMed ID: 12772050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis.
    Tack J; Depoortere I; Bisschops R; Verbeke K; Janssens J; Peeters T
    Aliment Pharmacol Ther; 2005 Nov; 22(9):847-53. PubMed ID: 16225494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric emptying in patients with Type 2 diabetes mellitus and diabetes associated with mitochondrial DNA 3243 mutation using 13C-octanoic acid breath test.
    Nohara S; Iwase M; Imoto H; Sasaki N; Nakamura U; Uchizono Y; Abe S; Doi Y; Iida M
    J Diabetes Complications; 2006; 20(5):295-301. PubMed ID: 16949516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes.
    Meier JJ; Gallwitz B; Salmen S; Goetze O; Holst JJ; Schmidt WE; Nauck MA
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2719-25. PubMed ID: 12788879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward office-based measurement of gastric emptying in symptomatic diabetics using [13C]octanoic acid breath test.
    Lee JS; Camilleri M; Zinsmeister AR; Burton DD; Choi MG; Nair KS; Verlinden M
    Am J Gastroenterol; 2000 Oct; 95(10):2751-61. PubMed ID: 11051344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnitude of slowing gastric emptying by glucagon-like peptide-1 receptor agonists determines the amelioration of postprandial glucose excursion in Japanese patients with type 2 diabetes.
    Suganuma Y; Shimizu T; Sato T; Morii T; Fujita H; Harada Sassa M; Yamada Y
    J Diabetes Investig; 2020 Mar; 11(2):389-399. PubMed ID: 31301103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity.
    Maselli DB; Camilleri M
    Adv Exp Med Biol; 2021; 1307():171-192. PubMed ID: 32077010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
    Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
    Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship among gastroparetic symptoms, quality of life, and gastric emptying in patients referred for gastric emptying testing.
    DiBaise JK; Patel N; Noelting J; Dueck AC; Roarke M; Crowell MD
    Neurogastroenterol Motil; 2016 Feb; 28(2):234-42. PubMed ID: 26547484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the GLP-1 receptor agonist lixisenatide on postprandial glucose and gastric emptying--preclinical evidence.
    Werner U
    J Diabetes Complications; 2014; 28(1):110-4. PubMed ID: 23992745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal hormonal dysfunction in gastroparesis and functional dyspepsia.
    Khoo J; Rayner CK; Feinle-Bisset C; Jones KL; Horowitz M
    Neurogastroenterol Motil; 2010 Dec; 22(12):1270-8. PubMed ID: 20939851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis.
    Ejskjaer N; Vestergaard ET; Hellström PM; Gormsen LC; Madsbad S; Madsen JL; Jensen TA; Pezzullo JC; Christiansen JS; Shaughnessy L; Kosutic G
    Aliment Pharmacol Ther; 2009 Jun; 29(11):1179-87. PubMed ID: 19298585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis.
    Tack J; Rotondo A; Meulemans A; Thielemans L; Cools M
    Neurogastroenterol Motil; 2016 Apr; 28(4):487-97. PubMed ID: 27010235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study.
    Murray CD; Martin NM; Patterson M; Taylor SA; Ghatei MA; Kamm MA; Johnston C; Bloom SR; Emmanuel AV
    Gut; 2005 Dec; 54(12):1693-8. PubMed ID: 16085693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exenatide effects on gastric emptying rate and the glucose rate of appearance in plasma: A quantitative assessment using an integrative systems pharmacology model.
    Voronova V; Zhudenkov K; Penland RC; Boulton DW; Helmlinger G; Peskov K
    Diabetes Obes Metab; 2018 Aug; 20(8):2034-2038. PubMed ID: 29663628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between glycemic control and gastric emptying in poorly controlled type 2 diabetes.
    Bharucha AE; Kudva Y; Basu A; Camilleri M; Low PA; Vella A; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):466-476.e1. PubMed ID: 25041866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of GLP-1 receptor agonists use in diabetic patients diagnosed with delayed gastric emptying and their demographic profile.
    Kalas MA; Dang TQ; Galura G; Alvarado L; Dwivedi AK; Deoker A; McCallum R
    J Investig Med; 2023 Jan; 71(1):11-16. PubMed ID: 36198436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.